CanSino Biologics' market value is the price at which a share of CanSino Biologics trades on a public exchange. It measures the collective expectations of CanSino Biologics investors about its performance. CanSino Biologics is trading at 4.47 as of the 18th of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 4.47. With this module, you can estimate the performance of a buy and hold strategy of CanSino Biologics and determine expected loss or profit from investing in CanSino Biologics over a given investment horizon. Check out CanSino Biologics Correlation, CanSino Biologics Volatility and CanSino Biologics Performance module to complement your research on CanSino Biologics.
It's important to distinguish between CanSino Biologics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CanSino Biologics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CanSino Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CanSino Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CanSino Biologics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CanSino Biologics.
0.00
11/20/2025
No Change 0.00
0.0
In 3 months and 1 day
02/18/2026
0.00
If you would invest 0.00 in CanSino Biologics on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding CanSino Biologics or generate 0.0% return on investment in CanSino Biologics over 90 days. CanSino Biologics is related to or competes with Sihuan Pharmaceutical, Curaleaf Holdings, Dermapharm Holding, Almirall, Fagron NV, and Aspen Pharmacare. CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China More
CanSino Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CanSino Biologics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CanSino Biologics upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for CanSino Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CanSino Biologics' standard deviation. In reality, there are many statistical measures that can use CanSino Biologics historical prices to predict the future CanSino Biologics' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as CanSino Biologics. Your research has to be compared to or analyzed against CanSino Biologics' peers to derive any actionable benefits. When done correctly, CanSino Biologics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in CanSino Biologics.
CanSino Biologics February 18, 2026 Technical Indicators
CanSino Biologics secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. CanSino Biologics exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CanSino Biologics' Standard Deviation of 2.58, risk adjusted performance of (0.09), and Mean Deviation of 0.9511 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.24, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CanSino Biologics' returns are expected to increase less than the market. However, during the bear market, the loss of holding CanSino Biologics is expected to be smaller as well. At this point, CanSino Biologics has a negative expected return of -0.34%. Please make sure to confirm CanSino Biologics' maximum drawdown, as well as the relationship between the kurtosis and day typical price , to decide if CanSino Biologics performance from the past will be repeated at some point in the near future.
Auto-correlation
0.63
Good predictability
CanSino Biologics has good predictability. Overlapping area represents the amount of predictability between CanSino Biologics time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CanSino Biologics price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current CanSino Biologics price fluctuation can be explain by its past prices.
Other Information on Investing in CanSino Pink Sheet
CanSino Biologics financial ratios help investors to determine whether CanSino Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CanSino with respect to the benefits of owning CanSino Biologics security.